Published on Apr 8, 2014
Takeda has been fined $6bn over alleged health risks of its Actos diabetes treatment. Eli Lilly, its US partner, must pay $3bn. Lex’s Oliver Ralph and Robert Armstrong discuss whether the drugs companies can recover from such hefty penalties.
Note: These corporations in their remorseless pursuit of profit at the behest of their investors and board have lost any moral or social capital to lead or dictate to humanity what is in our best interests.